0001586939-15-000001.txt : 20150107
0001586939-15-000001.hdr.sgml : 20150107
20150107174241
ACCESSION NUMBER: 0001586939-15-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150105
FILED AS OF DATE: 20150107
DATE AS OF CHANGE: 20150107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FATE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001434316
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3535 GENERAL ATOMICS COURT
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858.875.1803
MAIL ADDRESS:
STREET 1: 3535 GENERAL ATOMICS COURT
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flynn Peter D
CENTRAL INDEX KEY: 0001586939
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36076
FILM NUMBER: 15514379
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-01-05
0
0001434316
FATE THERAPEUTICS INC
FATE
0001586939
Flynn Peter D
C/O FATE THERAPEUTICS, INC.
3535 GENERAL ATOMICS COURT, SUITE 200
SAN DIEGO
CA
92121
0
1
0
0
See remarks
Common Stock
2015-01-05
4
A
0
2466
0
A
6505
D
Stock Option (right to buy)
4.835
2015-01-05
4
A
0
70000
A
2025-01-04
Common Stock
70000
70000
D
Represents shares issued pursuant to the Company's 2013 Stock Option and Incentive Plan as a portion of a bonus earned by the reporting person for the fiscal year ended December 31, 2014.
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 5, 2015 such that this option is fully exercisable on January 5, 2019.
Not applicable.
Senior Vice President, Early Program Development
/s/ Cindy R. Tahl, as Attorney-in-Fact
2015-01-07